Herpes simplex Virus 2 Glycoprotein G Antigen BA1052RVS-G

$1,054.00

Summary

Virion/Serion Immunologics Antigen for research use (RUO)
Herpes Simplex Virus (HSV) 2 Glycoprotein G Antigen, recombinant
Suitable for detection of IgA, IgG & IgM antibodies in ELISA
Lot specific concentration, specified in mg/mL
1 mg

SKU: BA1052RVS-G Category: Infectious disease proteins Tags: antigen, Herpes simplex Virus

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Herpes simplex Virus 2 Glycoprotein G
species reactivity	Herpes Simplex Virus
applications	ELISA
assay type	Indirect & quantitative
available size	1 mg

Herpes simplex Virus 2 Glycoprotein G Antigen BA1052RVS-G

kit
Research area Infectious Disease
Storage Store at -65°C. Avoid freeze/thaw cycles. Sonicate before use.
Form liquid
Associated products Herpes simplex Virus 2 Glycoprotein G Antigen (BA1052RVS-G) Herpes simplex Virus 2 Antigen (BA1052VS) Herpes Simplex Virus 2 gP IgG Control Serum (BC1052G) Herpes Simples Virus 2 IgM Control Serum (BC1052M) Herpes simplex Virus 2 IgG ELISA Kit (ESR1052G) Herpes simplex Virus 2 IgM ELISA Kit (ESR1052M)

target relevance
Organism Herpes Simplex Virus 1/2
Protein names Herpes Simplex Virus (HSV)
Structure and strains Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known by their taxonomic names Human alphaherpesvirus 1 and Human alphaherpesvirus 2, are two members of the human Herpesviridae family, a set of viruses that produce viral infections in the majority of humans. Both HSV-1 and HSV-2 are very common and contagious. They can be spread when an infected person begins shedding the virus. As of 2016, about 67% of the world population under the age of 50 had HSV-1. In the United States, about 47.8% and 11.9% are estimated to have HSV-1 and HSV-2, respectively, though actual prevalence may be much higher. Because it can be transmitted through any intimate contact, it is one of the most common sexually transmitted infections.
Detection and diagnosis An important field of application for HSV serology - also during latency - is the detection of serotype-specific HSV IgG antibodies in order to identify potential HSV carriers who could infect susceptible individuals. In particular, the identification of HSV 2 serotype-specific antibodies in pregnant women, who present a high risk of transferring the virus to a newborn child, is recommended. The serological typing of an HSV infection is usually performed by identifying IgG antibodies directed against the viral surface glycoproteins G (gG) of HSV 1 (gG1) and HSV 2 (gG2). Due to the fact that these antibodies are only produced some weeks after a primary infection, the determination of serotype-specific antibodies can also assist in the differentiation between primary infection and reactivation

Data

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.